Chris: Just a couple of months ago Gerald gave us LymPro revenue guidance and said the RUO market for LymPro in 2015 was 150 million, of which LymPro would get a "significant portion." Just a week ago Jason said the Lympro revenue in 2015 would be 1 million and in 2016 3.5 million. Chris, just 3 months ago you were telling me my LymPro revenue estimates of 30 million for 2015 were way too low! And, you thought my pps target for year end of .30 to .40 cents was way too low! Now you've abandoned Lympro revenue altogether and are off on another wild dream of Lympro being sold down the road!
Chris, with all due respect, you might have an advanced case of Retinitis Pigmentosa!! You're blind, man!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links